Literature DB >> 12297950

[Sucessful treatment with clofazimine and itraconazole in a 46 year old patient after 32 years duration of disease].

M Fischer1, A Chrusciak Talhari, D Reinel, S Talhari.   

Abstract

Lobomycosis, caused by the fungal pathogen Lacazia loboi, is a chronic deep mycosis and is only found in Central and South America. Clinically the disease is characterized by shiny keloidal nodules appearing mainly on the exposed parts such as face and the upper and lower extremities. Therapeutically the surgical removal of the lesions is considered as the only successful treatment. We describe the therapeutic response of a patient with Lobo's disease treated for one year with a combination of clofazimine (100 mg/day) and itraconazole (100 mg/day). A complete clinical and histopathological remission of the disease was observed. The patient has been followed for three years.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297950     DOI: 10.1007/s00105-002-0351-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  10 in total

1.  [Tropical dermatology training in the Bundeswehr: Deployment in Manaus, Brazil].

Authors:  M Fischer
Journal:  Hautarzt       Date:  2015-05       Impact factor: 0.751

2.  Lobomycosis successfully treated with posaconazole.

Authors:  Beatriz Bustamante; Carlos Seas; Martín Salomon; Francisco Bravo
Journal:  Am J Trop Med Hyg       Date:  2013-04-01       Impact factor: 2.345

Review 3.  Lobomycosis Epidemiology and Management: The Quest for a Cure for the Most Neglected of Neglected Tropical Diseases.

Authors:  Franciely G Gonçalves; Patrícia S Rosa; Andrea de F F Belone; Léia B Carneiro; Vania L Q de Barros; Rosineide F Bispo; Yally A da S Sbardelott; Sebastião A V M Neves; Amy Y Vittor; William J Woods; Gabriel Z Laporta
Journal:  J Fungi (Basel)       Date:  2022-05-10

4.  Lobomycosis: A case from Southeastern Europe and review of the literature.

Authors:  Evangelia Papadavid; Maria Dalamaga; Irini Kapniari; Ekaterini Pantelidaki; Sotirios Papageorgiou; Vassiliki Pappa; Panagiotis Tsirigotis; Ioannis Dervenoulas; Nikolaos Stavrianeas; Dimitrios Rigopoulos
Journal:  J Dermatol Case Rep       Date:  2012-09-28

5.  Case Report: Molecular Confirmation of Lobomycosis in an Italian Traveler Acquired in the Amazon Region of Venezuela.

Authors:  Anna Beltrame; Patrizia Danesi; Claudio Farina; Pierantonio Orza; Francesca Perandin; Claudia Zanardello; Paola Rodari; Silvia Staffolani; Zeno Bisoffi
Journal:  Am J Trop Med Hyg       Date:  2017-09-21       Impact factor: 2.345

6.  Nodules on the right ear.

Authors:  Carolina Talhari; Alexandra Maria Giovanna Brunasso; Sinesio Talhari; Cesare Massone
Journal:  Dermatol Pract Concept       Date:  2012-01-31

Review 7.  Lobomycosis: epidemiology, clinical presentation, and management options.

Authors:  Valeska Albuquerque Francesconi; Ana Paula Klein; Ana Paula Botelho Gualda Santos; Rajendranath Ramasawmy; Fábio Francesconi
Journal:  Ther Clin Risk Manag       Date:  2014-10-09       Impact factor: 2.423

8.  Lobomycosis in Soldiers, Colombia.

Authors:  Claudia M Arenas; Gerzain Rodriguez-Toro; Andrea Ortiz-Florez; Ingrid Serrato
Journal:  Emerg Infect Dis       Date:  2019-04       Impact factor: 6.883

9.  Human case of lobomycosis.

Authors:  Sameer Elsayed; Susan M Kuhn; Duane Barber; Deirdre L Church; Stewart Adams; Richard Kasper
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

10.  Lobomycosis: a therapeutic challenge.

Authors:  Marcelo Grossi Araújo; Nathalie Silva Cirilo; Soraya Neves Marques Barbosa Dos Santos; Claudemir Roberto Aguilar; Antonio Carlos Martins Guedes
Journal:  An Bras Dermatol       Date:  2018-03       Impact factor: 1.896

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.